Data / Form D filings / Comera Life Sciences Holdings, Inc.
Comera Life Sciences Holdings, Inc.: Form D filings
Comera Life Sciences Holdings, Inc., a biotechnology company in Woburn, MA, filed 4 Form D notices with the SEC between 2023 and 2024. The latest, on January 8, 2024, reports $1.5 million sold of a $1.5 million offering to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12 GILL STREET, SUITE 4650, Woburn, MA, 01801
- Phone
- (617) 871-2101
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1907685
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 8, 2024 | New notice | $1,500,000 | $1,500,000 | 12 | Dec 29, 2023 | sec.gov | |
| Aug 7, 2023 | New notice | $238,336 | $238,336 | 1 | Jul 31, 2023 | sec.gov | |
| Aug 7, 2023 | New notice | $4,070,000 | $2,249,000 | $1,821,000 | 12 | Jul 31, 2023 | sec.gov |
| Jan 12, 2023 | New notice | $3,561,250 | $3,561,250 | 14 | Jan 4, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| William A. Wexler | Director | |
| James Patrick Sherblom | Director | |
| Dorothy J. Clarke | Director | |
| Edward Aloysius Sullivan Jr. | Director | |
| Sirshendu Roopom Banerjee | Director | |
| Michael Gerard Campbell | Executive Officer | |
| Kirsten Roopom Flowers | Director | |
| Robert Patrick Mahoney | Executive Officer | |
| Jeffrey S. Hackman | Executive Officer, Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jan 8, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Comera Life Sciences Holdings, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.